Apple software updates for 2026 are now reaching supported devices, bringing iOS 27, iPadOS 27, macOS 27, watchOS 27, visionOS 27, and tvOS 27 out of preview and into everyday use. The releases place Siri AI and the next generation of Apple Intelligence at the center, but many of the changes extend well beyond generative AI.

The updates began rolling out September 14. Alongside new intelligence features, Apple has made measurable performance changes to iPhone and iPad, overhauled several parental controls, refined the Liquid Glass interface introduced across its platforms, improved search, and added smaller changes to services including iCloud Shared Albums, Maps, AirPods, and Health.

Siri AI is initially rolling out as a beta in English. Apple says French, Japanese, Korean, Portuguese, and Spanish support is scheduled for October, making some of the headline functionality a staggered release rather than something every user receives immediately after installing the new operating systems.

Apple software updates make Siri AI a cross-device feature

Siri AI is built around personal context, onscreen awareness, expanded app actions, and access to current information from the web. The assistant can draw on material stored in areas such as Messages, Mail, and Photos when responding to requests, while Visual Intelligence allows users to ask about content currently displayed on their screen.

On iPhone, Siri mode is integrated directly into the Camera app. A user can point the camera at something and ask questions or perform supported actions based on what appears in front of them.

The assistant also gains a dedicated Siri app that synchronizes conversation history privately through iCloud. A conversation started on an iPhone can therefore be continued on an iPad, Mac, Apple Watch, or Apple Vision Pro.

Write with Siri expands the assistant into text creation and editing. Users can describe the material they need drafted or ask Siri to refine existing writing without moving to a separate application.

Apple Intelligence is also adding more specialized features outside Siri. Photos receives Spatial Reframing, Extend, and an updated Clean Up tool. Image Playground can generate images in a wider selection of styles, including photorealistic output, with metadata designed to identify AI-created material and planned support for the SynthID standard.

Safari can automatically organize tabs by topic and monitor webpages for changes, such as a product returning to stock or a price dropping. Apple is also introducing tools that can create custom extensions from a description.

iOS 27 and iPadOS 27 put more emphasis on speed

Some of the less visible changes could be among the most frequently experienced.

Apple says apps can launch up to 30% faster on iPhone and iPad after installing the new software. Photos can load an image up to 70% faster immediately after it is taken, while AirDrop transfers can be up to 80% faster.

iPadOS 27 receives additional work around file handling and multitasking. Apple says browsing files and transferring them to an external USB drive can be as much as five times faster, accompanied by smoother window closing, switching, and dragging.

Connectivity behavior has also been adjusted. Transitions between cellular connections and Wi-Fi are designed to happen more seamlessly, while Messages no longer needs to hold subsequent texts behind a large photo or video being uploaded over a slow connection.

Search across Spotlight, Photos, and Mail has been revised on iPhone, iPad, and Mac. Mail gains a new ranking system for Top Hits, while Apple describes search across the three platforms as more stable and comprehensive.

Liquid Glass has received another round of refinements after becoming the common visual language across Apple’s software. A new Settings slider allows users to adjust the interface from an ultraclear appearance toward a more heavily tinted version, and app icons have been sharpened.

Screen Time and child safety controls get a substantial redesign

Apple has also expanded the controls available to families rather than limiting this software cycle to interface and AI work.

The setup process for child accounts now allows parents to specify which apps a child can access from the beginning, with additional apps added later if appropriate. Ask to Browse extends approval controls to Safari, letting parents require permission before a child opens a new website.

Communication Safety has been expanded beyond sexually explicit material to detect and intervene when gore or violent content appears in shared images and videos.

Screen Time presents average device usage and frequently used apps more prominently. Parents can establish daily time allowances across categories such as Entertainment, Games, and Social Media, while Schedules can change which apps remain available at different points during a weekday or weekend.

These changes are particularly notable because they work at the account and platform level rather than requiring parents to configure separate controls inside every individual app.

watchOS 27, visionOS 27, and tvOS 27 add targeted upgrades

The smaller platforms receive their own additions rather than simply inheriting features from iPhone and Mac.

watchOS 27 introduces a dedicated Siri app, a dynamic app grid, expanded Smart Stack suggestions, and a new single-handed tap gesture for opening widgets. Workout Buddy can now operate without the paired iPhone nearby, while Cycle Tracking in Health adds support related to perimenopause and menopause.

visionOS 27 brings Siri AI and Visual Intelligence into Apple Vision Pro, where the assistant can respond to objects a user is physically looking at. Panoramas can be converted into spatial scenes and used as personal Environments, while Mac users can bring compatible 3D models into their physical space to preview and edit them.

Apple says Vision Pro can now start up and connect to Wi-Fi up to three times faster. New curved windows, Control Center changes, eye-controlled notification expansion, and improvements to Dwell Control further adjust the spatial interface.

tvOS 27 takes a narrower approach. Apple Music gains high-resolution lossless audio support, Apple Podcasts has been redesigned, and additional text-size accessibility options have been introduced. Apple TV 4K owners can install the release on supported second- and third-generation models.

Other changes stretch across device categories. iCloud Shared Albums can now retain full-resolution photos and videos while making participation easier from Android and Windows devices. AirPods gain custom EQ settings, Maps expands Flyover with AI-assisted aerial detail, and Missed-message notifications and unread counts now synchronize more quickly and reliably across Apple devices.

With the September 14 releases now public, the software cycle shifts from preview demonstrations to staggered feature delivery. Siri AI language expansion begins in October, while some Apple Intelligence capabilities and individual app features will continue arriving through later updates rather than being tied exclusively to the initial 27.0 releases.

The post Apple software updates bring Siri AI and faster performance across devices appeared first on AppleMagazine.

Brings significant performance improvements when reading large files. ($59.99 new, free update, 32.2 MB, macOS 14+)

Adds the ability to to take a layered screenshot of all your open windows from the Dock menu. ($29.99 new, free update, 36.9 MB, macOS 14+)

Brings improvements and bug fixes to the Swiss Army knife of graphics programs. ($39.95 new, free update, 251.8 MB, macOS 10.13+)

At NAB 2026, Chuck Joiner talks with Ryan Burke, Portfolio Director for RØDE about the new RodeLink 2 UHF wireless system, developed with Lectrosonics expertise. The discussion covers interference-resistant UHF performance, 32-bit float recording, timecode, adaptive power, battery life, and removable storage media.  Ryan also provided a look at the new RODECaster Studio AI audio editing app for podcasters. 

💾

On the show floor at NAB in Las Vegas, Jim Tierney of Digital Anarchy discusses ShotNotes, a Premiere Pro panel that keeps project notes, time codes, links, timers, and collaboration details inside the edit instead of scattered across documents or sticky notes. He also previews Beauty Box Video AI development and explains where generative AI can help video pros, where traditional AI still shines, and why AI is useful but not a magic bullet. 

💾

In the Riverside booth at NAB in Las Vegas, Danielle Baxter, Business Development Representative, explains how the platform supports podcasting, video interviews, webinars, testimonials, and live streams. She covers options like local recording, separate audio and video tracks, browser-based guest access, built-in editing, branding, captions, producer mode, and flexible plans for solo creators and businesses. 

💾

From NAB in Las Vegas, Dan May, President of Blackmagic Design, talks about DaVinci Resolve 21, local AI tools, the new photo page, Blackmagic Cloud collaboration, Fairlight Live, and the free Blackmagic Camera app. The conversation highlights Blackmagic Design's focus on accessible professional tools and creator growth paths. 

💾

Adds a new Render to DNG option. ($9.99/$19.99/$59.99 monthly Creative Cloud subscription, free update, macOS 14+)

A couple of decades after the discovery of systems that could selectively target DNA, we're starting to see the first therapies based on gene editing. One challenge these developments have faced is safety. While we can make them pretty specific to the gene we want edited, the human genome is very large, and even rare DNA sequences can appear a couple of times by chance.

As a result, all the original gene-editing systems had known rates of what are called off-target effects, in which they simply edit the wrong sequence. This may be a low-probability event, but edit enough cells—and therapies generally have to edit many—and errors become inevitable.

A lot of effort has gone into finding ways to minimize or eliminate off-target edits. In a recent issue of Nature, researchers described modifying the AI protein-folding software AlphaFold to help identify key areas of gene-editing proteins responsible for off-target effects. Those areas were then modified to reduce the problems.

Read full article

Comments

© Anton Vierietin

A couple of decades after the discovery of systems that could selectively target DNA, we're starting to see the first therapies based on gene editing. One challenge these developments have faced is safety. While we can make them pretty specific to the gene we want edited, the human genome is very large, and even rare DNA sequences can appear a couple of times by chance.

As a result, all the original gene-editing systems had known rates of what are called off-target effects, in which they simply edit the wrong sequence. This may be a low-probability event, but edit enough cells—and therapies generally have to edit many—and errors become inevitable.

A lot of effort has gone into finding ways to minimize or eliminate off-target edits. In a recent issue of Nature, researchers described modifying the AI protein-folding software AlphaFold to help identify key areas of gene-editing proteins responsible for off-target effects. Those areas were then modified to reduce the problems.

Read full article

Comments

© Anton Vierietin

A Adobe anunciou a adição de novos recursos temporários impulsionados por inteligência artificial (IA) ao Project Indigo, seu app de câmera exclusivo para iOS, com a ferramenta AI Playground.

Os quatro principais recursos de IA do Project Indigo incluem a manipulação de objetos (Object Editing, ou “edição de objeto”, em tradução direta), a estilização de uma foto em uma determinada técnica artística (Styles, ou “estilos”), o feedback por IA das suas fotos (Photo Guidance, ou “orientação fotográfica”) e a edição a partir de comandos de linguagem natural (Custom Edit, ou “edição customizável”).

De forma opcional, a Adobe afirmou ainda que o acesso ao AI Playground estará restrito a uma parcela dos usuários do Project Indigo, sem menção aos critérios exatos de disponibilização. O teste ocorrerá durante algumas semanas e a ideia é compreender o uso de IA no app, embora ela reitere seus pilares de privacidade:

Quem aceitar participar precisará concordar em compartilhar apenas as interações com os botões do recurso. A Adobe afirma que não acessará os comandos digitados, nem as imagens, não fará upload delas para seus servidores e não as utilizará para treinar modelos de IA. Como não há login, todos os dados coletados são anônimos. Quem preferir não participar pode recusar e continuar usando o aplicativo normalmente.

Recursos como a estilização de fotos ou a remoção de objetos farão uso do modelo Nano Banana, do Google, ou dos próprios modelos Firefly da Adobe, mas ela reitera que o leque de modelos poderá se expandir no futuro.

Por fim, a Adobe explicou ainda que os modelos atuais de geração de imagens produzem apenas resultados com alcance dinâmico padrão (SDR ¹Standard dynamic range, ou faixa dinâmica padrão.) e, para preservar a aparência das fotos capturadas com HDR ²High dynamic range, ou ampla faixa dinâmica. pelo Project Indigo, a empresa desenvolveu um modelo próprio de ML ³Machine learning, ou aprendizado de máquina. que converte automaticamente o resultado gerado pela IA para HDR, utilizando a foto original como referência, sem empregá-la para treinar modelos de IA.

via TechCrunch

Notas de rodapé

• 1
  Standard dynamic range, ou faixa dinâmica padrão.
• 2
  High dynamic range, ou ampla faixa dinâmica.
• 3
  Machine learning, ou aprendizado de máquina.

Maintenance update that addresses reported issues for the venerable text editor. ($59.99 new, free update, 32.2 MB, macOS 14+)

Maintenance release for the writing app with a few bug fixes. ($5.99/$39.99 monthly/yearly subscription, free update, 63.3 MB, macOS 14+)

Brings new Cropping and Brush functionality, as well as new automation capabilities. ($29.99 new, free update, 36.9 MB, macOS 14+)

Cadmium (Cd) contamination is a growing threat to food safety, and rice is one of the most vulnerable crops. Because rice plants can accumulate cadmium from contaminated soils more readily than many other staples, Cd can become a major dietary exposure route for large parts of the world’s population. Yet attempts to lower cadmium often create trade-offs—reducing uptake of essential nutrients or weakening plant performance.

A new study from Okayama University, Japan, and collaborating researchers in China reports a precision-editing strategy designed to avoid those trade-offs. The team focused on the rice metal transporter gene OsNramp5, which is known to move metals such as manganese and cadmium, and used base-editing to search for a beneficial point mutation within the gene rather than disabling it.

Using adenine and cytosine base editors, the researchers generated more than 1,600 genome-edited rice lines and screened them for reduced cadmium accumulation. Their saturation mutagenesis approach targeted OsNramp5 to identify variants that kept normal plant physiology while limiting Cd buildup in grain.

The key breakthrough was the I441T substitution: changing isoleucine to threonine at amino acid position 441. This single change reduced cadmium levels in both shoots and brown rice without altering gene expression, protein abundance, or the subcellular localization of the transporter.

Importantly, the mutation did not come at the cost of micronutrients. Field trials on cadmium-contaminated soil showed a 48% decrease in cadmium concentration in brown rice, from 0.14 mg/kg in wild type to 0.07 mg/kg in the edited plants, while iron, manganese, and zinc levels remained essentially unchanged.

The researchers then explored the mechanism behind the selective effect. Although OsNramp5 transports multiple metals, the I441T mutation shifted its selectivity—enhancing zinc transport preference. Increased zinc accumulation in root cells promoted competitive inhibition against cadmium during root-to-shoot movement.

Instead of completely blocking cadmium uptake, the edited transporter selectively limited cadmium translocation, reducing grain contamination while preserving essential mineral delivery. The team supported these conclusions with physiological assessments, gene and protein analyses, yeast transport assays, and agronomic evaluation.

Overall, the work demonstrates how precision genome editing can address a long-standing breeding challenge: lowering toxic metal accumulation without disrupting nutrient homeostasis. The researchers propose that the OsNramp5^I441T allele could accelerate development of safer rice varieties for mildly contaminated regions.

Subject of Research: Not applicable
Article Title: Genome-edited rice variety with low-cadmium accumulation in the grain
News Publication Date: 18-Jun-2026
Web References: http://dx.doi.org/10.1073/pnas.2610609123
References: DOI: 10.1073/pnas.2610609123 (Proceedings of the National Academy of Sciences)
Image Credits: Credit: Professor Jian Feng Ma from Okayama University, Japan

Keywords: cadmium, rice, OsNramp5, base editing, genome editing, metal transporters, food safety, micronutrients, zinc competition, plant breeding

A University of Queensland breakthrough could soon be used to upgrade the world’s most prominent gene-editing technology to

In a groundbreaking study poised to redefine cancer immunotherapy paradigms, researchers have unveiled a programmable RNA engineering platform that restores immune recognition in notoriously immune-resistant tumors such as prostate cancer. This innovative approach, centered on precise manipulation of mRNA alternative polyadenylation (APA), revives the expression of major histocompatibility complex class I (MHC-I) molecules — the pivotal sentinels of immune surveillance routinely downregulated in these tumors. The findings, detailed in Nature Biomedical Engineering, shed light on an elusive molecular mechanism of immune evasion and herald a new frontier in translational cancer immunology.

Prostate cancer and analogous immune-cold tumors have long bedeviled clinicians by resisting immune checkpoint inhibitor therapies, a frontline strategy in modern oncology. A primary culprit in this resistance is the diminished presentation of tumor-specific antigens on MHC-I molecules, molecules intrinsically responsible for flagging abnormal cells to cytotoxic CD8 T cells. Without adequate MHC-I display, these malignant cells evade immune detection, rendering checkpoint blockade largely ineffective. Despite the clinical significance, no therapies have yet emerged that selectively restore MHC-I expression, underscoring a critical unmet medical need.

The investigative team addressed this gap by engineering the 3′UTR CRISPR/dCas13 system (3′UTRCES), an advanced RNA-editing platform designed to modulate mRNA 3′ untranslated region (3′UTR) dynamics in vivo. Unlike conventional gene editing tools that alter DNA sequences, 3′UTRCES uniquely targets RNA transcripts’ polyadenylation sites to manipulate APA patterns — a post-transcriptional regulatory mechanism influencing mRNA stability, localization, and translation. Leveraging a catalytically inactive Cas13 (dCas13) fused to programmable effectors, this system reprograms 3′UTR architecture to reinstate normal gene expression profiles critical for immune function.

Central to their discovery is the identification of tumor-specific 3′UTR shortening in the E3 ubiquitin ligase adaptor SPSB1, a molecular player hitherto not linked to immune modulation. Through sophisticated analyses, the researchers demonstrated that aberrant SPSB1 3′UTR truncations promote enhanced ubiquitination and subsequent degradation of MHC-I molecules. This selective downregulation disrupts the immune system’s ability to recognize and eliminate malignant cells without affecting programmed death-ligand 1 (PD-L1), an immune checkpoint protein. These insights decode a novel mechanism by which tumors suppress antigen presentation, bypassing immune control.

Armed with this mechanistic understanding, the team deployed lipid nanoparticle (LNP) delivery of the 3′UTRCES constructs directly into syngeneic mouse models harboring prostate tumors. This therapeutic intervention reversed the aberrant SPSB1 3′UTR shortening, effectively restoring MHC-I expression on tumor cells. The restored antigen presentation reinvigorated the infiltration of CD8 cytotoxic T lymphocytes, amplifying antitumor immune responses and sensitizing tumors to subsequent immune checkpoint therapies. This combinatorial strategy outperformed existing modalities, offering a tangible path to overcome immune resistance.

The implications of this study extend beyond prostate cancer, representing a conceptual shift in targeting post-transcriptional gene regulation to modulate tumor immunity. By precisely tailoring RNA isoforms through 3′UTRCES, it becomes feasible to rectify pathological gene expression patterns without permanent genomic alterations, minimizing off-target effects and paving the way for tunable, reversible therapies. This technological stride potentially positions LNP-3′UTRCES as a versatile platform for broad-spectrum cancer immunotherapy.

Delving deeper into the molecular underpinnings, the research highlights how alternative polyadenylation — once considered a subtle nuance of gene regulation — plays an outsized role in immune evasion. APA events that truncate key regulatory 3′UTRs can rewire protein expression profiles, impacting ubiquitin-mediated degradation pathways. In SPSB1’s case, 3′UTR shortening shields MHC-I from stable expression, underscoring the delicate interplay between RNA processing and immune visibility. These revelations chart a new investigative avenue for uncovering APA-driven oncogenic mechanisms.

The study harnessed state-of-the-art transcriptomic and proteomic methodologies to validate the APA signatures and subsequent functional outcomes. Single-cell RNA sequencing and cross-linking immunoprecipitation unveiled the precise RNA-protein interactions modulated by 3′UTR alterations. Meanwhile, in vivo tumor growth assays meticulously quantified the therapeutic efficacy of 3′UTRCES-mediated intervention. The robust experimental design marries molecular biology with immuno-oncology, reinforcing the translational promise of RNA engineering.

Beyond prostate cancer, the researchers posit that similar APA-driven immune escape mechanisms may underpin resistance in other malignancies characterized as immune-cold or immunologically excluded. Tumor heterogeneity presents obstacles, yet the adaptability of the 3′UTRCES platform offers a pathway to customize RNA editing interventions tailored to tumor-specific APA landscapes. This precision medicine approach aligns with emerging oncology paradigms striving to unify genetic and epigenetic therapeutic targeting.

Crucially, this work confronts a longstanding conceptual bottleneck — the absence of clinically viable modalities to restore MHC-I expression selectively. Immune checkpoint inhibitors, though transformative, rely heavily on intact antigen presentation machinery to elicit durable responses. By restoring the tumor’s antigen-presenting capacity, 3′UTRCES synergizes with immune checkpoint blockade, reinvigorating exhausted cytotoxic T cells and promoting tumor clearance. This paradigm underscores the importance of targeting upstream immune suppression pathways in cancer.

The LNP delivery mechanism employed is equally noteworthy, showcasing advances in nanomedicine that enable precise nucleic acid transport to tumor sites. Lipid nanoparticles offer biocompatibility, customizable surface chemistry, and efficient endosomal escape — attributes critical for clinical translation. As the field gravitates toward RNA-based therapeutics post-COVID-19, leveraging these delivery systems in oncology sets a precedent for future innovations combining synthetic biology and immunotherapy.

Looking ahead, the scalability and safety of 3′UTRCES-mediated therapies warrant thorough exploration through preclinical and clinical studies. Immunogenicity of RNA-guided effectors, off-target RNA interactions, and durability of therapeutic responses remain important considerations. Nevertheless, the current findings provide a compelling proof of concept, invigorating translational research efforts to combat immune escape mechanisms effectively.

This pioneering research not only reframes our understanding of tumor immune evasion but also exemplifies how RNA technology can be harnessed to unlock therapeutic opportunities in recalcitrant cancers. By transforming APA from a molecular signature of immune suppression into a therapeutic target, the study opens vistas for next-generation cancer treatments that restore immune competence at the RNA level. This convergence of molecular biology, immunotherapy, and RNA engineering heralds a new dawn in oncology innovation.

In summary, the programmable editing of mRNA 3′UTRs via the 3′UTRCES platform revitalizes MHC-I expression in prostate tumors, counteracting immune suppression driven by SPSB1-mediated degradation pathways. This novel mechanistic insight, coupled with effective lipid nanoparticle delivery and demonstrated synergy with immune checkpoint inhibitors, marks a transformative advance in overcoming tumor immune resistance. The study exemplifies how precision RNA engineering can recalibrate tumor immunogenicity and redefine therapeutic potentials in cancer treatment.

As research continues to unravel the complexities of RNA-mediated regulation of immune visibility in cancer, the integration of programmable RNA tools like 3′UTRCES with established immunotherapies holds immense promise. These synergistic strategies may soon accelerate the development of personalized cancer therapies designed to circumvent immune escape and foster more durable clinical remissions. The future of oncology may indeed lie at the interface of RNA engineering and immunomodulation.

This landmark work not only elucidates a previously unrecognized molecular mechanism of immune evasion but also delivers a versatile, programmable therapeutic platform for precise post-transcriptional gene regulation in cancer. Its translational implications inspire optimism for expanding the repertoire of RNA-based interventions that can be tailored to diverse tumor contexts, ultimately enhancing patient outcomes and transforming cancer immunotherapy at its molecular roots.

---

Subject of Research: Programmable RNA engineering to restore MHC-I expression and overcome immune evasion in prostate cancer.

Article Title: Programmable mRNA 3′UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer.

Article References:
Huang, F., Yuan, F., Li, K. et al. Programmable mRNA 3′UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer. Nat. Biomed. Eng (2026). https://doi.org/10.1038/s41551-026-01720-9

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41551-026-01720-9